Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases
- PMID: 32693768
- DOI: 10.2174/1570161118666200721145718
Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases
Abstract
In Part 1 of this Thematic Issue entitled "Systemic Autoimmune Rheumatic Diseases and Cardiology", a panel of specialists and experts in cardiology, rheumatology, immunology and related fields discussed the cardiovascular complications of spondyloarthritides, rheumatoid arthritis, Sjogren's syndrome and vasculitides, as well as relevant cardiovascular issues related to non-biologic and biologic disease-modifying anti-rheumatic drugs (DMARDs), and provided their recommendations for prevention and management of these complications. In part 2 of this Thematic Issue, experts discuss the enhanced cardiovascular risk conferred by additional autoimmune rheumatic diseases (ARDs), including systemic lupus erythematosus, the antiphospholipid syndrome, psoriasis and psoriatic arthritis and juvenile idiopathic arthritis. These, and the previous articles, place inflammation as the key common link to explain the enhanced risk of cardiovascular complications in patients with ARDs. It follows that treatment should probably target inflammation. From all these contemporary reviews, the conclusion that is derived further supports the notion of the emerging field of Cardio- Rheumatology where physicians and experts from these two disciplines collaborate in risk stratification and optimization of preventive strategies and drug therapies in patients with ARDs.
Keywords: Autoimmune rheumatic disease; acute coronary syndromes; antiphospholipid syndrome; antirheumatic drugs; atherosclerosis; cardiorheumatology; cardiovascular disease; cardiovascular imaging; coronary artery disease; juvenile idiopathic arthritis; myocardial infarction; psoriasis; psoriatic arthritis; stroke; systemic lupus erythematosus.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target?Curr Vasc Pharmacol. 2020;18(5):425-430. doi: 10.2174/1570161118666200514222236. Curr Vasc Pharmacol. 2020. PMID: 32410564
-
Cardiovascular Consequences of Autoimmune Rheumatic Diseases.Curr Vasc Pharmacol. 2020;18(6):566-579. doi: 10.2174/1570161118666200127142936. Curr Vasc Pharmacol. 2020. PMID: 31985379 Review.
-
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management.Autoimmun Rev. 2017 Sep;16(9):911-924. doi: 10.1016/j.autrev.2017.07.012. Epub 2017 Jul 11. Autoimmun Rev. 2017. PMID: 28705780 Review.
-
The Corrona US registry of rheumatic and autoimmune diseases.Clin Exp Rheumatol. 2016 Sep-Oct;34(5 Suppl 101):S96-S99. Epub 2016 Oct 19. Clin Exp Rheumatol. 2016. PMID: 27762197 Review.
-
Accelerated Atherosclerosis and Management of Cardiovascular Risk in Autoimmune Rheumatic Diseases: An Updated Review.Curr Probl Cardiol. 2023 Dec;48(12):101999. doi: 10.1016/j.cpcardiol.2023.101999. Epub 2023 Jul 26. Curr Probl Cardiol. 2023. PMID: 37506959 Review.
Cited by
-
The impact of biologic agents on cardiovascular risk factors in patients with rheumatoid arthritis: A meta analysis.PLoS One. 2024 Aug 29;19(8):e0306513. doi: 10.1371/journal.pone.0306513. eCollection 2024. PLoS One. 2024. PMID: 39208032 Free PMC article.
-
Challenges in Implementing Cardiovascular Risk Scores for Assessment of Young People With Childhood-Onset Autoimmune Rheumatic Conditions.Front Med (Lausanne). 2022 Feb 14;9:814905. doi: 10.3389/fmed.2022.814905. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35237628 Free PMC article.
-
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis.Sci Rep. 2022 May 7;12(1):7498. doi: 10.1038/s41598-022-11640-8. Sci Rep. 2022. PMID: 35525861 Free PMC article.
-
Cardiovascular Events, Sleep Apnoea, and Pulmonary Hypertension in Primary Sjögren's Syndrome: Data from the French Health Insurance Database.J Clin Med. 2021 Oct 30;10(21):5115. doi: 10.3390/jcm10215115. J Clin Med. 2021. PMID: 34768635 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical